PARIO GROUP LIMITED

Financial Health Assessment: PARIO GROUP LIMITED

1. Financial Health Score: B- While the patient is in stable condition with a strong historical constitution, the latest examination reveals a worrying acute decline in vitality. A significant drop in revenue and a collapse in profitability, combined with a halving of cash reserves and dividend payouts exceeding actual profits, are symptoms of financial stress. However, a robust equity base and manageable current liabilities keep the overall health score from dropping to a lower grade.

2. Key Vital Signs * Heartbeat (Revenue): Slowing. Group turnover dropped from £27.8 million in 2023 to £23.5 million in 2024—a 15.5% deceleration. In the medical recruitment sector, this indicates a loss of momentum or reduced client demand. * Blood Pressure (Cash Reserves): Dropping. Cash at bank fell sharply from £857,326 to £402,864. This severe drop in the business's lifeblood requires immediate monitoring to ensure it doesn't hemorrhage further. * Cholesterol (Debt & Interest): Elevated. Interest payable and similar expenses remain high at £102,267. With operating profits falling, this financial cholesterol is clogging the arteries, making it harder for profits to flow down to the bottom line. * Immune System (Equity Base): Strong. Total equity stands at a healthy £1,252,242. This historical reserve acts as a powerful immune system, ensuring the company can withstand short-term shocks without facing immediate insolvency. * Metabolism (Administrative Costs): Sluggish. Admin expenses dropped slightly from £3.57 million to £3.06 million, but not nearly enough to match the drop in gross profit. The business is burning energy inefficiently relative to its new, lower income levels.

3. Symptoms Analysis The financial data reveals several underlying symptoms of distress: * Profit Hemorrhage: While gross profit margins remained relatively stable (around 14%), the operating profit was halved, falling from £395,939 to £233,711. Profit before tax saw an even steeper plunge from £246,450 to £52,457. This indicates that the cost structure is not responding well to the drop in revenue. * Dead Tissue (Write-offs): The 2024 accounts show an £78,987 write-off of investments. This suggests past capital allocations did not yield the expected returns, essentially removing healthy tissue from the balance sheet. * Overexertion (Dividend Payouts): The company paid out £83,000 in dividends despite only making a net profit of £16,480. Paying out five times the actual profit drains the retained earnings, effectively bleeding the company's reserves to reward shareholders.

4. Diagnosis Acute Profitability Shock with Cash Dehydration. The company is suffering from a severe contraction in profitability driven by falling revenues and an inflexible cost base. The high debtors figure (£3.23 million) suggests that while the company is generating sales, it may be acting as a bank for the NHS or other medical clients—funding payroll before receiving cash. The decision to pay out dividends well in excess of profits suggests a potential misalignment between shareholder expectations and the current financial reality.

5. Prognosis Guarded. The company's historical equity reserves provide a buffer against immediate fatality, meaning insolvency is not a near-term risk. However, if the revenue contraction continues or if the high debtors are not converted into cash, the business could quickly face a liquidity crisis. The medical staffing industry requires strong cash flow to fund temporary workers' wages; without it, operational capacity will be severely restricted.

6. Recommendations * Fluid Resuscitation (Cash Flow Management): Aggressively manage debtors. With £3.23 million owed within the year, improving collection times is critical to restoring healthy cash levels without resorting to expensive debt. * Diet and Exercise (Cost Restructuring): Administrative expenses must be surgically reviewed. A 15% drop in revenue should be met with a corresponding restructuring of overheads to restore operating margins. * Rest and Recovery (Halt Dividend Drain): The patient must stop bleeding reserves. Until profitability is restored, dividends should be suspended or heavily reduced to match actual net profits, preserving the equity "immune system". * Cholesterol Management (Debt Review): Review the structure of the debt causing over £100k in interest charges. Refinancing or paying down expensive debt will relieve pressure on the profit and loss statement.